Finepoint Capital LP
Q4 2024 13F Holdings
- Locationboston, MA
- Num holdings
26
- Value ($000)
$1,637,498
- Date Filed02/13/2025
- Form type13F-HR
- CIK0001608126
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
---|---|---|---|---|---|---|---|
SPY SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | $442.49M | 27 % | 755,000 | put | |
QXO QXO INC | COM NEW | 82846H405 | $396.45M | 24 % | 24,933,825 | ||
IWM ISHARES TR | RUSSELL 2000 ETF | 464287655 | $328.13M | 20 % | 1,485,000 | put | |
LBRDK Liberty Broadband Corp | COM SER C | 530307305 | $150.69M | 9 % | 2,015,710 | ||
LLYVK LIBERTY MEDIA CORP DEL | COM LBTY LIV S C | 531229722 | $55.32M | 3 % | 812,792 | ||
ARGX Argenx SE | SPONSORED ADR | 04016X101 | $32.55M | 2 % | 52,928 | ||
RVMD REVOLUTION MEDICINES INC | COM | 76155X100 | $31.07M | 2 % | 710,260 | ||
SWTX SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | $27.05M | 2 % | 748,752 | ||
ASND ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | $25.45M | 2 % | 184,872 | ||
MLTX MoonLake Immunotherapeutics | CLASS A ORD | 61559X104 | $24.26M | 2 % | 447,935 |
Rows Per Page
1 - 10 of 2610
- 10
- 50
- 100